On the other hand, for HFrEF there are multiple drugs including angiotensin converting enzyme inhibitors (ACE-i) or angiotensin receptor blockers (ARB), β-blockers, and mineralocorticoid receptor antagonists (MRA), and devices that reduce mortality and heart failure hospitalization as it does improve quality of life [1]. This evidence concerns the gene ACE and heart failure.